MétaCan
Menu
Back to cohort
Record W2099799455 · doi:10.1093/jnci/djq494

Genetic Variation at 9p22.2 and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers

2010· article· en· W2099799455 on OpenAlexafffund
Susan J. Ramus, Christiana Kartsonaki, S. Gayther, Paul D.P. Pharoah, Olga M. Sinilnikova, Jonathan Beesley, X. Chen, L. McGuffog, Sue Healey, Fergus J. Couch, X. Wang, Zachary Fredericksen, Paolo Peterlongo, Siranoush Manoukian, Bernard Peissel, Daniela Zaffaroni, Gaia Roversi, Monica Barile, Alessandra Viel, Anna Allavena, Laura Ottini, Laura Papi, Viviana Gismondi, F Capra, Paolo Radice, Mark H. Greene, P. L., I. L. Andrulis, Gord Glendon, Hilmi Özçelik, M. Thomassen, Anne‐Marie Gerdes, Torben A. Kruse, D. G. Crüger, Uffe Birk Jensen, Maria A. Caligo, Håkan Olsson, Ulf Kristoffersson, Annika Lindblom, Brita Arver, Per Karlsson, Marie Stenmark Askmalm, Åke Borg, Susan L. Neuhausen, Yuan Chun Ding, Katherine L. Nathanson, S. M. Domchek, Anna Jakubowska, Jan Lubiński, Tomasz Huzarski, Tomasz Byrski, J. Gronwald, B. Gorski, Cezary Cybulski, Tadeusz Dębniak, Ana Osório, M. Durán, María‐Isabel Tejada, Javier Benítez, U. Hamann, Matti A. Rookus, Senno Verhoef, M. A. Tilanus-Linthorst, Maaike P.G. Vreeswijk, Daniëlle Bodmer, Margreet G.E.M. Ausems, T. A. van Os, Christi J. van Asperen, Marinus J. Blok, Hanne Meijers‐Heijboer, S. Peock, Margaret Cook, Clare Oliver, D Frost, Alison M. Dunning, D. Gareth Evans, Rosalind A. Eeles, Gabriella Pichert, T Cole, Shirley Hodgson, C Brewer, P. J. Morrison, M. Porteous, M. John Kennedy, Mark T. Rogers, Lucy Side, Alan Donaldson, Helen Gregory, Andrew K. Godwin, D Stoppa-Lyonnet, V. Moncoutier, Laurent Castéra, Sylvie Mazoyer, L. Barjhoux, Valérie Bonadona, Dominique Leroux, Laurence Faivre, Rosette Lidereau, Catherine Noguès, Y.-J. Bignon, Fabienne Prieur, Marie‐Agnès Collonge‐Rame, Laurence Venat‐Bouvet, Sandra Fert‐Ferrer, Alexander Miron, Saundra S. Buys, J. L. Hopper, Mary B. Daly, Esther M. John, Mary Beth Terry, Thomas van Overeem Hansen, Lars Jønson, Bent Ejlertsen, Bjarni A. Agnarsson, Kenneth Offit, Tomas Kirchhoff, Joseph Vijai, Ana Dutra-Clarke, Jennifer A. Przybylo, Marco Montagna, C. Casella, Evgeny N. Imyanitov, Ramūnas Janavičius, Ignacio Blanco, Conxi Lázaro, Kirsten B. Moysich, Beth Karlan, Jenny Gross, Michael S. Beattie, Rita K. Schmutzler, Barbara Wappenschmidt, Alfons Meindl, I. Ruehl, Britta Fiebig, Christian Sutter, Norbert Arnold, Heidrun L. Deissler, R. Varon-Mateeva, Karin Kast, D. Niederacher, Dorothea Gadzicki, Trinidad Caldés, Miguel de la Hoya, Heli Nevanlinna, Kristiina Aittomäki, Jacques Simard, Penny Soucy, Amanda B. Spurdle, H. Kent Holland, Georgia Chenevix‐Trench, D. F. Easton, Antonis C. Antoniou

Bibliographic record

VenueJNCI Journal of the National Cancer Institute · 2010
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBRCA gene mutations in cancer
Canadian institutionsUniversité LavalCancer Care OntarioUniversity of Toronto
FundersNational Institute for Health and Care ResearchCanadian Institutes of Health ResearchNational Cancer InstituteCancer Research UKNational Institutes of HealthU.S. Public Health Service
KeywordsOvarian cancerMutationGeneticsGenetic variationBiologyBRCA2 ProteinVariation (astronomy)OncologyCancerGermline mutationMedicineGene

Abstract

fetched live from OpenAlex

BACKGROUND: Germline mutations in the BRCA1 and BRCA2 genes are associated with increased risks of breast and ovarian cancers. Although several common variants have been associated with breast cancer susceptibility in mutation carriers, none have been associated with ovarian cancer susceptibility. A genome-wide association study recently identified an association between the rare allele of the single-nucleotide polymorphism (SNP) rs3814113 (ie, the C allele) at 9p22.2 and decreased risk of ovarian cancer for women in the general population. We evaluated the association of this SNP with ovarian cancer risk among BRCA1 or BRCA2 mutation carriers by use of data from the Consortium of Investigators of Modifiers of BRCA1/2. METHODS: We genotyped rs3814113 in 10,029 BRCA1 mutation carriers and 5837 BRCA2 mutation carriers. Associations with ovarian and breast cancer were assessed with a retrospective likelihood approach. All statistical tests were two-sided. RESULTS: The minor allele of rs3814113 was associated with a reduced risk of ovarian cancer among BRCA1 mutation carriers (per-allele hazard ratio of ovarian cancer = 0.78, 95% confidence interval = 0.72 to 0.85; P = 4.8 × 10(-9)) and BRCA2 mutation carriers (hazard ratio of ovarian cancer = 0.78, 95% confidence interval = 0.67 to 0.90; P = 5.5 × 10(-4)). This SNP was not associated with breast cancer risk among either BRCA1 or BRCA2 mutation carriers. BRCA1 mutation carriers with the TT genotype at SNP rs3814113 were predicted to have an ovarian cancer risk to age 80 years of 48%, and those with the CC genotype were predicted to have a risk of 33%. CONCLUSION: Common genetic variation at the 9p22.2 locus was associated with decreased risk of ovarian cancer for carriers of a BRCA1 or BRCA2 mutation.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.008

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.004
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.000
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.301
Teacher spread0.286 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations51
Published2010
Admission routes2
Has abstractyes

Explore more

Same venueJNCI Journal of the National Cancer InstituteSame topicBRCA gene mutations in cancerFrench-language works237,207